We are live on ! Find out more
ISL

Ingalls & Snyder LLC Portfolio holdings

AUM $2.83B
1-Year Est. Return 21.61%
This Fund
S&P 500
This Quarter Est. Return
+5.67%
1 Year Est. Return
+21.61%
3 Year Est. Return
+166.27%
5 Year Est. Return
+212.01%
10 Year Est. Return
+695.23%
AUM
$1.95B
AUM Growth
+$108M
Cap. Flow
+$36.7M
Cap. Flow %
1.88%
Top 10 Hldgs %
38.39%
Holding
457
New
17
Increased
108
Reduced
186
Closed
24

Top Buys

Rank Stock Value
1
CORT icon
Corcept Therapeutics
CORT
+$33.9M
2
CNQ icon
Canadian Natural Resources
CNQ
+$5.27M
3
PXD
Pioneer Natural Resource Co.
PXD
+$4.97M
4
PAAS icon
Pan American Silver
PAAS
+$3.54M
5
OMER icon
Omeros
OMER
+$3.53M

Top Sells

Rank Stock Value
1
CNCE
Concert Pharmaceuticals, Inc.
CNCE
+$7.57M
2
INTC icon
Intel
INTC
+$951K
3
HXL icon
Hexcel
HXL
+$791K
4
NVEI
Nuvei Corporation Subordinate Voting Shares
NVEI
+$777K
5
MSFT icon
Microsoft
MSFT
+$687K

Sector Composition

Rank Sector Weight
1 Healthcare 21.25%
2 Energy 17.15%
3 Technology 13.62%
4 Financials 12.38%
5 Industrials 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BBVA icon
401
Banco Bilbao Vizcaya Argentaria
BBVA
$154B
$74K ﹤0.01%
10,474
– –
BRN icon
402
Barnwell Industries
BRN
$14.8M
$67K ﹤0.01%
30,610
– –
CVX icon
403
CALL
Chevron
CVX
$392B
$65K ﹤0.01%
400
– –
NGD
404
DELISTED
New Gold Inc
NGD
$63K ﹤0.01%
57,325
– –
SAN icon
405
Banco Santander
SAN
$201B
$62K ﹤0.01%
16,904
– –
FTCH
406
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
$59K ﹤0.01%
11,932
+3,997
+50% +$21.7K
CDLX icon
407
Cardlytics
CDLX
$21.7M
$58K ﹤0.01%
1,701
-375
-18% -$19.6K
GTE icon
408
Gran Tierra Energy
GTE
$265M
$46K ﹤0.01%
5,223
-30
-0.6% -$259
CSBR icon
409
Champions Oncology
CSBR
$74.5M
$44K ﹤0.01%
11,056
– –
SPY icon
410
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$790B
$41K ﹤0.01%
100
– –
DVLT
411
Datavault AI
DVLT
$291M
$33K ﹤0.01%
140
– –
SCOR icon
412
Comscore
SCOR
$106M
$29K ﹤0.01%
1,190
-26
-2% -$632
CVM icon
413
CEL-SCI Corp
CVM
$20.3M
$23K ﹤0.01%
337
-53
-14% -$4.15K
INUV icon
414
Inuvo
INUV
$15.1M
$22K ﹤0.01%
7,500
– –
FROG icon
415
CALL
JFrog
FROG
$9.66B
$20K ﹤0.01%
1,000
– –
FTCH
416
CALL
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
$20K ﹤0.01%
4,000
-14,000
-78% -$76K
HRTX icon
417
Heron Therapeutics
HRTX
$93.9M
$17K ﹤0.01%
11,415
– –
GAN
418
DELISTED
GAN Ltd
GAN
$14K ﹤0.01%
10,850
-20,000
-65% -$36.4K
SLV icon
419
CALL
iShares Silver Trust
SLV
$28B
$13K ﹤0.01%
600
– –
MAPS
420
DELISTED
WM TECHNOLOGY INC A
MAPS
$12K ﹤0.01%
13,900
– –
OMER icon
421
CALL
Omeros
OMER
$857M
$12K ﹤0.01%
+2,500
New +$9.03K
PIII icon
422
P3 Health Partners
PIII
$32.7M
$11K ﹤0.01%
200
– –
OPFI.WS
423
DELISTED
OppFi Inc Warrants
OPFI.WS
$8K ﹤0.01%
88,175
– –
ALL icon
424
Allstate
ALL
$68B
– –
-1,698
Closed -$230K
BAC icon
425
CALL
Bank of America
BAC
$435B
– –
-2,400
Closed -$79K
14 15 16
17
18

Similar funds

GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
AF
Aviso Financial Toronto, Ontario, Canada $2.82B AUM 24.96% 1-Year Est. Return
AIP
Atlas Infrastructure Partners London, United Kingdom $2.84B AUM 4.75% 1-Year Est. Return
SAI
Systematic Alpha Investments Princeton, New Jersey $2.84B AUM 27.03% 1-Year Est. Return
GI
GLOBALT Investments Atlanta, Georgia $2.8B AUM 21.13% 1-Year Est. Return
MWM
Meridian Wealth Management Lexington, Kentucky $2.85B AUM 31.23% 1-Year Est. Return
MSDF
Michael & Susan Dell Foundation New York $2.85B AUM 26.28% 1-Year Est. Return
SHIM
Spruce House Investment Management New York $2.8B AUM 65.68% 1-Year Est. Return

Ingalls & Snyder LLC's Q1 2023 Portfolio in Review

As of Q1 2023, Ingalls & Snyder LLC held 457 positions worth $1.95B, up 5.9% from $1.84B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Ingalls & Snyder LLC's Q1 2023 filing shows 17 new, 108 increased, 186 reduced and 24 closed positions. Its largest new stake was TSMC: 31,331 shares worth $2.91M. The largest sale was Concert Pharmaceuticals, Inc., an estimated $7.57M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Energy and Technology.

  • Ingalls & Snyder LLC's largest Q1 2023 buy was TSMC: 31,331 shares worth $2.91M.
  • Ingalls & Snyder LLC added most to Corcept Therapeutics in Q1 2023, an estimated $33.9M increase.
  • Ingalls & Snyder LLC's biggest Q1 2023 reduction was Intel, cutting an estimated $951K.
  • Ingalls & Snyder LLC fully exited Concert Pharmaceuticals, Inc. in Q1 2023, selling an estimated $7.57M.
  • Ingalls & Snyder LLC's ten largest holdings make up 38% of its $1.95B portfolio in Q1 2023.
  • Ingalls & Snyder LLC opened 17 new positions and closed 24 in Q1 2023.
  • Ingalls & Snyder LLC's portfolio value rose 5.9% quarter-over-quarter to $1.95B.

Based on Ingalls & Snyder LLC's 13F filing for Q1 2023, filed 9 May 2023.